Lawrence Baldini is President & VP at MERIDIAN BIOSCIENCE INC (VIVO). They have made 14 open-market trades across 1 company since 2007, most recently 2018-12-15.
CIK 0001224664
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $935K since 2009, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VIVO | 75,528 | $158K |
Shares reported on the most recent Form 4, priced at the 2019-02-25 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VIVO | SELL | 2018-11-12 | 2018-11-14 | $19.41 | $1.4M | -5.5% | -9.1% | -15.2% |
| VIVO | BUY | 2017-01-26 | 2017-01-30 | $12.70 | $51K | -0.4% | +1.2% | +17.9% |
| VIVO | BUY | 2016-11-03 | 2016-11-07 | $16.00 | $78K | +6.2% | +9.5% | -22.2% |
| VIVO | SELL | 2013-11-19 | 2013-11-21 | $24.26 | $120K | -10.2% | -3.7% | -3.7% |
| VIVO | SELL | 2013-07-26 | 2013-07-30 | $24.14 | $772K | -10.2% | -3.7% | -3.7% |
| VIVO | BUY | 2012-12-04 | 2012-12-05 | $20.07 | $652K | -10.2% | -3.7% | -3.7% |
| VIVO | SELL | 2012-12-03 | 2012-12-05 | $20.00 | $650K | -10.2% | -3.7% | -3.7% |
| VIVO | SELL | 2010-12-07 | 2010-12-09 | $23.00 | $234K | -10.2% | -3.7% | -3.7% |
| VIVO | BUY | 2009-04-17 | 2009-04-21 | $15.38 | $154K | -10.2% | -3.7% | -3.7% |
| VIVO | SELL | 2008-02-26 | 2008-02-27 | $35.13 | $439K | -10.2% | -3.7% | -3.7% |
| VIVO | SELL | 2008-01-23 | 2008-01-25 | $34.00 | $536K | -10.2% | -3.7% | -3.7% |
| VIVO | SELL | 2007-07-27 | 2007-07-31 | $23.00 | $173K | -10.2% | -3.7% | -3.7% |
| VIVO | SELL | 2007-02-01 | 2007-02-05 | $29.55 | $177K | -10.2% | -3.7% | -3.7% |
| VIVO | SELL | 2007-01-22 | 2007-01-24 | $28.05 | $196K | -10.2% | -3.7% | -3.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.